Rabbit Polyclonal to p300 – Targeting the ubiquitin–proteasome system for cancer therapy

Neuronal nicotinic acetylcholine receptors (nAChR), identified targets for drug development in

December 4, 2018 by Katherine Lewis Leave a Comment

Neuronal nicotinic acetylcholine receptors (nAChR), identified targets for drug development in cognitive and neuro-degenerative disorders, are allosteric proteins with powerful interconversions between multiple useful states. ion route activation. While these brand-new drugs appear appealing for therapeutic advancement, we also consider potential caveats and feasible limitations for his or her make use of, including PAM-insensitive types … [Read more…]

Cocaine binds and inhibits dopamine transporter (DAT), norepinephrine transporter (NET) and

August 13, 2018 by Katherine Lewis Leave a Comment

Cocaine binds and inhibits dopamine transporter (DAT), norepinephrine transporter (NET) and serotonin transporter. 2 placement of cocaine analogs. These email address details are in keeping with our previously suggested cocaine-DAT binding model where cocaine in the beginning binds to a niche site that will not overlap with, but is usually near, the dopamine-binding site. Computational … [Read more…]